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Mouse Embryonic Stem Cells Are Deficient in Type I
Interferon Expression in Response to Viral Infections and
Double-stranded RNA*□
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Embryonic stem cells (ESCs) are considered to be a promising
cell source for regenerative medicine because of their unlimited
capacity for self-renewal and differentiation. However, little is
known about the innate immunity in ESCs and ESC-derived
cells. We investigated the responses of mouse (m)ESCs to three
types of live viruses as follows: La Crosse virus, West Nile virus,
and Sendai virus. Our results demonstrated mESCs were susceptible to viral infection, but they were unable to express type I
interferons (IFN␣ and IFN␤, IFN␣/␤), which differ from fibroblasts (10T1/2 cells) that robustly express IFN␣/␤ upon viral
infections. The failure of mESCs to express IFN␣/␤ was further
demonstrated by treatment with polyIC, a synthetic viral dsRNA
analog that strongly induced IFN␣/␤ in 10T1/2 cells. Although
polyIC transiently inhibited the transcription of pluripotency
markers, the stem cell morphology was not significantly
affected. However, polyIC can induce dsRNA-activated protein
kinase in mESCs, and this activation resulted in a strong inhibition of cell proliferation. We conclude that the cytosolic receptor dsRNA-activated protein kinase is functional, but the mechanisms that mediate type I IFN expression are deficient in
mESCs. This conclusion is further supported by the findings
that the major viral RNA receptors are either expressed at very
low levels (TLR3 and MDA5) or may not be active (retinoic acidinducible gene I) in mESCs.

Embryonic stem cells (ESCs)3 have attracted enormous
attention in recent years with the expectation that they will be
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used as a source for cell-based therapy. Although the benefit of
this research in medical applications is exciting, currently there
is limited understanding of the basic physiology of ESCs and
their derived cells. When used for cell therapy, ESC-derived
cells would be placed in a wounded area that is likely to be
exposed to various pathogens. Therefore, their fate and functionality may depend on their innate immunity to deal with a
hostile environment. However, it is not clear whether ESCs and
ESC-derived cells have functional innate immunity.
Derived from an early stage embryo, ESCs can divide continuously under proper culture conditions. When induced, they
can differentiate into different cell lineages, a property known
as pluripotency (1, 2). Study of the molecular mechanisms that
control ESC differentiation, pluripotency, and self-renewal has
been the center of ESC research. Recent studies have led to the
development of methods for ESC differentiation into different
cell types. However, it is increasingly clear that generating clinically usable cells is a task that faces many biological and technical challenges. For instance, it is well recognized that if ESCs
are not fully differentiated and transplanted to the patient, they
can grow into tumor-like structures known as teratomas (3).
However, there are many other concerns that have not been
fully recognized. An outstanding issue is the cellular innate
immunity, which is not easily recognized in the cells that are not
challenged by infectious agents. This concern is illustrated with
the case of ESC-derived endothelial cells. These cells have been
well characterized with respect to the endothelial cell marker
expression, morphology, and the ability to form vessels (4, 5).
However, only a few studies (6 – 8), including our own (9), have
investigated their innate immune and inflammatory responses.
Such studies have demonstrated that ESC-endothelial cells,
derived from both human and mouse ESCs (hESC and mESCs),
have limited, if any, ability to respond to lipopolysaccharides
and inflammatory cytokines. Apparently, the failure of in vitro
ESC-differentiated cells to acquire active innate immunity
could be a concern for clinical applications.
tein kinase; ICAM1, intercellular cell adhesion molecule-1; m.o.i., multiplicity of infection; RT-qPCR, real time quantitative-PCR; ssRNA, singlestranded RNA; 3p-ssRNA, 5⬘-triphosphate single-stranded RNA.
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Background: The antiviral mechanisms are not known in mESCs.
Results: mESCs are susceptible to viral infections and dsRNA-inhibited cell proliferation but do not express type I interferons.
Conclusion: mESCs have underdeveloped mechanisms for type I interferon expression.
Significance: The findings are important for understanding the development of antiviral mechanisms in ESCs and stem cell
physiology.

mESCs Are Deficient in Type I IFN Expression

EXPERIMENTAL PROCEDURES
mESC Culture—D3 cells, a commonly used mESC line in the
literature (18), were obtained from the ATCC. They were used
for the majority of the experiments in this study. The key experiments were repeated in DBA252 mESCs that we previously
characterized (19 –21). Both cell lines were maintained in the
standard mESC medium (21). Raw 264.7 (Raw) and 10T1/2
cells were cultured in DMEM that contains 10% fetal calf
serum, 100 units/ml penicillin, and 100 g/ml streptomycin.
All cells were maintained at 37 °C in a humidified incubator
with 5% CO2.
Preparation of Viral Stocks—La Crosse virus (LACV, SM6 v3)
and West Nile virus (WNV, strain CT2741) were propagated in
Vero cells (African green monkey kidney cell line, ATCC).
Titers of virus stocks were determined by plaque assay as
described previously (22). Sendai virus (SeV, Cantell strain)
stock was purchased from Charles River laboratory.
Cell Treatment—mESCs and 10T1/2 were plated at ⬃40 and
⬃70% confluence, respectively, and cultured for 24 h before the
experiments. For viral infection, viral stocks were added to the
cell culture at the concentrations as specified in individual
experiments. PolyIC (Sigma) was either directly added to the
cell culture or was transfected into the cells with DharmaFECT
MAY 31, 2013 • VOLUME 288 • NUMBER 22

reagent (Thermo Scientific). For polyIC transfection experiments, control cells were transfected with DharmaFECT reagent only. The culture medium and treated cells were collected
at different time periods and used for various analyses.
Real Time Quantitative-PCR (RT-qPCR)—Total RNA was
extracted using TRI Reagent (Sigma). cDNA was prepared by
Moloney murine leukemia virus reverse transcriptase (Sigma).
RT-qPCR was performed using SYBR Green ready mix on an
MX3000PTM RT-PCR system (Stratagene), as reported previously (21). The mRNA level from RT-qPCR was calculated
using the comparative Ct method (23). ␤-Actin mRNA was
used as a calibrator for the calculation of relative mRNA of the
tested genes. The sequences of the primer sets are listed in
supplemental Table 1.
IFN␤ and Cytokine Assays—The culture medium collected
from treated cells was used to determine secreted IFN␤ and
cytokines. IFN␤ was quantified with an ELISA kit that detects
mouse IFN␤ (PBL Biomedical Laboratories) according to the
manufacturer’s instruction. IL6 and TNF␣ were analyzed with a
Luminex cytokine assay kit (Millipore) and determined with a
MAGPIX instrument. The data were analyzed according to the
method described by Prabhakar et al. (24).
Cell Proliferation, Viability, and Cell Cycle Analysis—Cell
proliferation was determined by colony size and by cell number
after toluidine blue staining as we described previously (25).
The absorbance at 630 nm of toluidine blue-stained cells was
measured with a microtiter plate reader. The values, which correlate with the number of viable cells, were used as an indirect
measurement of cell proliferation or viability. Cell cycle analysis
by flow cytometry was performed after the cells were stained
with 50 g/ml propidium iodide. The cell cycle profiles were
generated with the CFlow software (25).
Protein Analysis by Flow Cytometry—Cellular protein analysis by flow cytometry was performed according to our published method (26). Briefly, treated cells were incubated with
the antibodies against the specific proteins to be analyzed. The
cells were then incubated with secondary antibodies conjugated with fluorescein isothiocyanate (FITC) and examined by
an Accuri C6 flow cytometer. The fluorescence intensity, which
correlates with the protein level, was determined with the
CFlow software. In some experiments, cells were doubly
stained with propidium iodide so that the expression level of
the protein in different phases of the cell cycle could be simultaneously determined.
siRNA Transfection—siRNAs targeting PKR and RIG-I or
negative control siRNA (Santa Cruz Biotechnology) were transfected to mESCs with DharmaFECT reagent at a final concentration of 100 nM. The cells were then analyzed for siRNA
knockdown efficiency or used for the experiments as specified.
Cell Lysate Preparation and Western Blot Analysis—Cells
were directly lysed with SDS sample buffer that contains 150
mM NaCl, 10 mM NaF, and 0.25 mM NaVO4. Western blot analysis was carried out as described previously (25).
Immunostaining Assay—Virus-infected cells were fixed with
4% paraformaldehyde for 15 min at room temperature. Cells
were washed with PBS containing 0.3% hydrogen peroxide to
block endogenous peroxidase activity for 30 min. Cells were
blocked with 2% normal goat serum with 0.4% Triton X-100
JOURNAL OF BIOLOGICAL CHEMISTRY
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Cellular innate immunity is mediated by pattern recognition
receptors that include toll-like receptors (TLRs) and retinoic
acid-inducible gene I (RIG-I)-like receptors. TLRs are localized
on the cell surface or on the membrane of endosomes where
they detect a wide variety of molecules that evoke immune
responses, known as pathogen-associated molecular patterns
(10). RIG-I-like receptors, including RIG-I and MDA5 (melanoma differentiation-associated gene 5), reside in the cytosol
and primarily recognize viral RNA (11). Upon binding with
their ligands, these receptors activate signaling pathways,
including interferon regulatory factor and nuclear transcription factor-B (NF-B), which coordinately regulate the
expression of type I interferons (IFN␣/␤) and pro-inflammatory cytokines that participate in antiviral responses (10, 12).
Another important molecule that mediates the effects of
dsRNA in the cytosol is dsRNA-activated protein kinase (PKR).
In addition to selectively activating the transcription of genes
involved in the immune responses, PKR also causes a general
inhibition of transcription, translation, and host cell proliferation that limits viral replication (13, 14). Although extensive
studies have been conducted in differentiated cells, only a few
studies have investigated the innate immunity in ESCs. It is
speculated that ESCs, normally residing in the sterile environment of the womb, may not have active innate immunity (15).
In line with this notion, recent studies indicated that hESCs do
not respond to a wide range of infectious agents, including bacterial LPS and dsRNA (6, 16). Similar to hESCs, it was shown
that mESCs did not respond to LPS (7) or even live bacteria (17).
However, the molecular mechanisms involved have not been
elucidated.
In this study, we demonstrated that mESCs are susceptible to
viral infections and dsRNA-inhibited cell proliferation, but they
are unable to express type I IFN. We provided molecular basis
for the underdeveloped antiviral mechanisms in mESCs.

mESCs Are Deficient in Type I IFN Expression
and incubated overnight at 4 °C with affinity-purified and antiflavivirus envelope protein monoclonal antibody (4G2, ATCC).
The cells were washed with PBS and then incubated with
secondary antibodies conjugated to HRP (horseradish peroxidase) for 2 h at room temperature. Positive cells were identified
using a TrueBlue detecting kit (KPL) under a phase contrast
microscope.
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RESULTS
mESCs Are Susceptible to the Cytopathic Effects of LACV
Infection—To investigate the responses of mESCs to viral infection, we first infected cells with LACV (a negative sense ssRNA
virus) that is known to cause lytic cell death of mammalian cells
(27). 10T1/2 cells, a mouse cell line with fibroblast properties
(28), were used as a positive control. Following the infection
with LACV (m.o.i. ⫽ 1), cytopathic effects were observed at
48 h post-infection in 10T1/2 cells. These effects included cell
morphological changes, such as rounding up and detachment
from the culture dish. Similar effects were observed in mESCs
at a longer incubation time (⬎60 h) (Fig. 1A, indicated by
arrows). Viral infection of mESCs was confirmed by expression
of the LACV gene that encodes the M-segment protein (Gc
protein) (29). The infected cells were immunostained monoclonal antibodies against the Gc protein (a gift from Dr. Samantha
Soldan, University of Pennsylvania School of Medicine) followed by flow cytometry analysis (29). As shown in Fig. 1B, the
expression of Gc protein was detected at 30 h and was significantly increased at 40 h post-infection.
The cytopathic effect of LACV was proportional to viral load
as indicated by the reduced number of viable cells at different
multiplicities of infection (Fig. 1, C and D). LACV infection also
caused cell cycle inhibition as indicated by an apparent reduction of cells in the G2 phase (Fig. 1E, indicated by arrow) and a
reduced expression level of cyclin E (Fig. 1F). Therefore, the
reduced cell number of mESCs by LACV infection could be due
to the lytic cell death as well as a general inhibition of cell proliferation associated with viral infection.
mESCs Are Deficient in Expressing Type I IFN in Response to
Viral Infection—Under the normal conditions, very low mRNA
levels of IFN␣ and IFN␤ were detected in 10T1/2 cells and were
nearly undetectable in mESCs. LACV infection induced about a
1900-fold increase of IFN␤ in 10T1/2 at an m.o.i. of 1, but the
induction in mESCs was negligible even at an m.o.i. of 10 (Fig.
2A). In addition, LACV infection up-regulated the expression
of IFN␣/␤ and the major viral RNA receptors, including RIG-I,
PKR, MDA5, and TLR3, to different degrees in 10T1/2 cells, but
such effects were not observed in mESCs (Fig. 2A). These
results indicated that mESCs are susceptible to LACV infection, but they are unable to effectively express IFN␣ and IFN␤.
To determine whether this observation is a general property
of mESC or it is an event specific to LACV infection, we tested
two additional viruses, WNV (a positive sense ssRNA virus) and
SeV (a negative sense ssRNA virus). In both cases, viral infection induced a large increase of IFN␤ transcription in 10T1/2
cells, but induction in mESCs was less than 5-fold (Fig. 2, B and
C). Viral infectivity in both mESCs and 10T1/2 cells was confirmed by expression of viral proteins. WNV E glycoprotein
(30) was detected with monoclonal antibodies (4G2, ATCC) by

FIGURE 1. Infection of mESCs and 10T1/2 cells with LACV. A, mESCs (D3)
and 10T1/2 cells were infected with LACV (m.o.i. ⫽ 1). The cells were examined under a phase contrast microscope and photographed (⫻400) at 48 h for
10T1/2 cells and 60 h for D3 cells. Arrows denote detaching dead cells.
B, detection of LACV Gc protein in D3 cells infected with LACV (m.o.i. ⫽ 10) by
flow cytometry. The expression level was proportional to fluorescence (Flu)
intensity. C, D3 and 10T1/2 cells were infected with LACV at an m.o.i. of 1.
Viable cells were determined at 48 h post-infection by toluidine blue cell
staining. The values are means ⫾ S.D. of a representative experiment performed in biological triplicates. D, D3 cells were infected with LACV at a different m.o.i. as indicated. Viable cells were determined at 48 h post-infection
as described in C. E, D3 cells were infected with LACV (m.o.i. ⫽ 10). The cell
cycle profiles and cell count were determined with CFlow software. Reduction of the G2 phase cells was indicated by the arrow. F, cyclin E expression
level in LACV-infected D3 cells described in E (40 h) was determined by flow
cytometry. The control (Con) represents cells without viral infection. All experiments were performed at least twice with similar results.
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RT-PCR and analyzed by agarose gel electrophoresis. ␤-Actin was used as a
loading control (inset). All results shown in the graphs are expressed as fold
activation, where the mRNA level in control cells is designated as 1 (not
shown). The values are means ⫾ S.D. of three independent experiments. The
experiments shown in the insets were performed twice with similar results.
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FIGURE 2. Viral infection-induced expression of IFN␣ and IFN␤ in D3 and
10T1/2 cells. A, 10T1/2 and D3 cells were infected with LACV at an m.o.i. of 1
and 10, respectively. The mRNA levels of the tested genes were determined
by RT-qPCR 24 h post-infection. B, 10T1/2 and D3 cells were infected with
WNV at an m.o.i. of 5 and 10, respectively. The mRNA levels of IFN␣ and IFN␤
were determined by RT-qPCR 24 h post-infection (graph). Infected cells were
immunostained with antibodies against WNV E glycoprotein, and immunopositive cells were stained dark blue (inset). C, 10T1/2 and D3 cells were
infected with SeV at 300 hemagglutination units/ml. The mRNA levels of IFN␤
were determined by RT-qPCR 12 and 24 h post-infection (graph). The transcription of SeV nucleocapsid protein in infected cells was determined by

immunostaining (Fig. 2B, inset), whereas SeV nucleocapsid
protein (31) was detected by RT-PCR analysis (Fig. 2C, inset).
Although WNV or SeV infection caused a slight but consistent
inhibition of cell proliferation, they did not cause apparent lytic
cell death as LACV (data not shown).
mESCs Can Sense and Respond to dsRNA via Cytosolic Receptors but Fail to Produce Functional IFN␤ and IL6—We further
analyzed the responses of mESCs to polyIC, a synthetic analog
of viral dsRNA that is widely used to mimic viral infection (32).
When directly added to the cell culture, polyIC is expected to
bind to TLR3 at the cell surface or to be internalized into the
endosomes where it activates TLR3 (33, 34). This was demonstrated in Raw cells where polyIC induced the expression of
IFN␣ and IFN␤, but not in mESCs (data not shown), indicating
that mESCs may not have functional TLR3 and/or a functional
mechanism for polyIC internalization. However, when transfected into cells, polyIC can induce a several-fold increase of the
transcription of three types of molecules typically seen in antiviral responses as follows: type I IFN (IFN␣/␤), inflammatory
cytokines (TNF␣ and IL1␣), and the cell adhesion molecule
(VCAM1) in D3 mESCs (Fig. 3A). Similar results were obtained
in another line of mESCs, DBA252 (Fig. 3B). These results
imply that mESCs can sense and respond to dsRNA via cytoplasmic receptors. However, the induction of IFN␤ in mESCs
was negligible when compared with 10T1/2 cells, whereby
polyIC induced nearly a 4000-fold increase of IFN␤ mRNA.
PolyIC-induced transcription of IL6 and ICAM1 was also substantially higher in 10T1/2 cells than in mESCs (Fig. 3C). When
examined at the protein level by ELISA, neither IFN␤ nor IL6
was detected in the media collected from polyIC-transfected
mESCs, although they were readily detected in the samples
from Raw cells and 10T1/2 cell cultures (Fig. 3D). Similar
results were obtained for TNF␣ (data not shown). Similarly,
ICAM1 protein was induced by polyIC transfection in 10T1/2
cells, but not in mESCs, as analyzed by flow cytometry of the
cells immunostained with anti-ICAM1 antibodies (Santa Cruz
Biotechnology) (Fig. 3E). Therefore, transfected polyIC could
elicit a limited increase of transcripts of the above mentioned
immune mediators in mESCs, but their corresponding proteins
were not detected.
PolyIC Transfected to mESCs Inhibits Cell Proliferation—
The most notable effect of transfected polyIC on mESCs at the
cellular level was the inhibition of cell proliferation. As shown
in Fig. 4, the colonies of polyIC-transfected cells were much
smaller than the control colonies (Fig. 4A), correlating with
markedly reduced cell numbers (Fig. 4B). In control cells, about
60% of cells were in the S phase, but polyIC caused an apparent
reduction of cells in the S and G2/M phases (Fig. 4C, indicated
by arrow and arrowhead, respectively). A time course analysis
revealed that the effects of polyIC can be detected as early as 6 h
(Fig. 4D). It is noted that polyIC transfection also caused a small
number of apoptotic cells (floating cells, data not shown),

mESCs Are Deficient in Type I IFN Expression

which may also contribute to the reduced cell number and colony size.
Because the constitutive activation of CDK2 by cyclin A and
E is the key factor that drives the rapid cell proliferation in
mESCs (35), we examined the effects of polyIC on the expression of these cell cycle regulators. The reduced expression of
cyclin E was apparent at 6 h after treatment, and this trend
lasted for 24 h, as determined with its antibodies (Santa Cruz
Biotechnology) by flow cytometry (Fig. 4E). Although cyclin A
was not affected at 6 and 12 h, it was reduced at 24 h. A similar
pattern was also demonstrated in the expression levels of CDK1
and CDK2 (data not shown). The CDKIs, including p16, p19,
and p21, are expressed at very low levels in control cells, and
polyIC did not affect their expression (data not shown). These
results suggest that down-regulation of cyclin E, and to a lesser

15930 JOURNAL OF BIOLOGICAL CHEMISTRY

extent cyclin A, CDK1, and CDK2, contributed to polyIC-inhibited cell proliferation.
Effect of PolyIC on the Stem Cell State—To test if the stem cell
state of mESCs was affected by polyIC, we examined the mRNA
levels of pluripotency markers in polyIC-transfected cells. They
were transiently down-regulated at 6 and 12 h but recovered
nearly to the level of the controls by 24 h (Fig. 5A). In agreement
with mRNA change, the protein level of OCT4, a key gene in the
pluripotency control network (1), displayed a similar pattern
with an initial slight decrease but returned to the normal levels
at 24 h (Fig. 5B). Interestingly, the transcription of several early
differentiation markers showed a similar dynamic pattern (Fig.
5C) to the pluripotency markers (Fig. 5A). Because of polyICinduced cell cycle inhibition, the colonies formed from polyICtransfected cells were smaller than those formed from control
VOLUME 288 • NUMBER 22 • MAY 31, 2013
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FIGURE 3. PolyIC transfected to mESCs can induce low level transcription of immune mediators but fail to produce detectable proteins. A–C, D3,
DBA252, and 10T1/2 were transfected with 300 ng/ml polyIC. mRNA was analyzed by RT-qPCR. The results are expressed as fold-activation where the mRNA
level in control cells is designated as 1. The values in A and C are means ⫾ S.D. of three independent experiments. The values in B are means ⫾ S.D. of a
representative experiment performed in biological triplicates. D, D3 and 10T1/2 were transfected with polyIC as described in A and C. For Raw cells, polyIC (25
g/ml) was directly added to the culture medium. The culture medium collected at different time points was analyzed for IFN␤ by ELISA (detectable range
15.6 –1000 pg/ml) and IL6 by Luminex assay (detectable range 0.64 –10,000 pg/ml). ND, not detected. The values for IFN␤ are means ⫾ S.D. of a representative
experiment performed in triplicate. The values for IL6 are average of a representative experiment performed in duplicate. E, expression profiles of ICAM1 in
10T1/2 and in D3 cells determined by flow cytometry. The representative experiments in all panels were repeated at least twice with similar results. Con, control.

mESCs Are Deficient in Type I IFN Expression

cells, but their overall morphology (round with densely packed
undifferentiated cells) was not significantly changed, as examined at 40 h (as shown in Fig. 4A) or at 72 h post-transfection
(Fig. 5D).
Relative Expression Levels of dsRNA Receptors in mESCs and
10T1/2 Cells—To identify the receptor(s) that mediate the
effects of transfected polyIC, we analyzed the relative expression levels of the four dsRNA receptors. The mRNA level of
each molecule was determined by RT-qPCR and compared
with that of ␤-actin. In D3 cells, TLR3 is expressed at a very low
level, and MDA5 is barely detected, although RIG-I and PKR
are expressed at higher levels (Fig. 6A). A similar pattern was
seen in DBA252 cells (Fig. 6B). When compared with 10T1/2
cells, the mRNA of TLR3 and MDA5 in D3 cells are negligible,
although RIG-I is about one-third of that in 10T1/2 cells. However, PKR is expressed at similar levels in the two types of cells
(Fig. 6C).
MAY 31, 2013 • VOLUME 288 • NUMBER 22

PKR Plays a Key Role in Mediating the Effects of PolyIC in
mESCs—The higher basal expression levels of PKR and RIG-I
in mESCs make them the likely candidates that mediate the
effects of polyIC. We first investigated PKR by its ability to
phosphorylate eukaryotic initiation factor 2␣ (eIF2␣). It is
known that phosphorylation of eIF2␣ by PKR attenuates its
function in translation, thereby resulting in protein synthesis
inhibition (13). PolyIC indeed stimulated eIF2␣ phosphorylation in mESCs as determined by flow cytometry and confirmed
by Western blot analysis using antibodies that specifically recognize phosphorylated eIF2␣ (p-eIF2␣, Cell Signaling),
although the expression of PKR did not change significantly.
p-eIF2␣ was detected as early as 30 min after polyIC transfection (Fig. 7A, boxed areas), which preceded cell cycle inhibition.
Pretreatment of the cells with a PKR inhibitor C16 (Sigma)
blocked polyIC-induced eIF2␣ phosphorylation (data not
shown), indicating that PKR is the responsible kinase. These
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 4. Effects of polyIC on mESC colony formation and cell proliferation. A–C, D3 cells were transfected with 300 ng/ml polyIC. Control (Con) represents
cells transfected with DharmaFECT without polyIC. After incubation for 40 h, the colonies were examined under a phase contrast microscope and photographed with a digital camera (⫻100, upper panels; ⫻400, lower panels) (A). Cell proliferation was measured by cell number indirectly determined from
toluidine blue staining (absorbance at 630 nm). The values are means ⫾ S.D. of an experiment performed in biological triplicate (B). Cell cycle was analyzed by
flow cytometry. The cell cycle profiles and cell count were determined with a computer software. Reduction of the S and G2/M phase cells were indicated by the
arrow and arrowhead, respectively (C). D, D3 cells were transfected with polyIC and incubated for the times as indicated. The cell cycle progression was analyzed
by flow cytometry as described in C. E, effect of polyIC on cyclin E expression was determined by flow cytometry after immunostaining of the cells with
antibodies against cyclin E. All representative experiments were performed at least twice with similar results.

mESCs Are Deficient in Type I IFN Expression

FIGURE 5. Effects of polyIC on the expression of pluripotency/differentiation markers and cell/colony morphology of mESCs. D3 cells were transfected with 300 ng/ml polyIC and incubated for a time course of 24 h. The
mRNA levels of pluripotency markers (A) and early differentiation markers (C)
were determined by RT-qPCR. The results are means ⫾ S.D. of three independent experiments. The effect of polyIC on the protein level of Oct 4 was
determined by flow cytometry. ⫺1st AB represents the experiments where
the cells were not incubated with anti-Oct4 antibodies (1st antibodies) as the
control (B). The effect of polyIC on cell/colony morphology was examined
under a phase contrast microscope and photographed with a digital camera
at 72 h after treatment (⫻400). The images are representative experiments
performed at least three times (D). Con, control.

results were confirmed with siRNA targeting PKR, which attenuated eIF2␣ phosphorylation, although the negative control
siRNA had no effect (Fig. 7B, upper panels, boxed areas).
Importantly, silencing PKR reversed polyIC-induced reduction
of S and G2/M phase cells (Fig. 7B, middle panels) as well as
reduced colony size (Fig. 7B, lower panels). However, knocking
down RIG-I did not show such effects. These data demonstrate
that PKR, not RIG-I, plays a key role in mediating polyIC-induced cell cycle inhibition.
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DISCUSSION
In this study, we investigated the responses of mESC to three
types of live viruses and two synthetic viral dsRNA analogs.
Althoug all of these stimuli induced a robust IFN␣/␤ expression
in 10T1/2 cells, they only induced very limited or no detectable
transcription of IFN␣/␤. These results suggest that mESCs are
deficient in type I IFN expression, a central component of the
antiviral mechanisms in most types of somatic cells.
It is known that many viruses have developed certain mechanisms to avoid the host antiviral responses. Repressing
IFN␣/␤ induction in host cells is one such mechanism (36).
However, the capacity of these viruses to repress IFN␣/␤ induction seems to depend on the types of host cells, as we demonstrated in 10T1/2 cells in which LACV can induce strong transcription of Ifn␣/␤ as well as the key components involved in
IFN␣/␤ expression, such as Rig-I, Mda5, and Tlr3. The induction of IFN␤ by WNV and SeV in 10T1/2 cells was also significant. Therefore, the failure to express IFN␣/␤ in mESCs is not
virus-specific or due to the IFN evasion strategies of viruses.
This conclusion is in line with the observations recently
reported by Wash et al. (37) that herpes simplex virus type I
(HSV-1, a DNA virus) and influenza virus (a negative sense
ssRNA virus) caused cytopathic effects without evoking type I
IFN induction. Together with results from the experiments
with polyIC and 3p-ssRNA,4 which mimic viral RNA in inducing a robust IFN␣/␤ expression in 10T1/2 cells but not in
mESCs, we conclude that deficiency in type I IFN expression is
an intrinsic property of mESCs.
We have provided the molecular basis that explains the
defective IFN␣/␤ expression in mESCs. In some cell types,
polyIC can induce IFN␣/␤ via activation of TLR3 at the cell
surface or in the endosomes (11, 38, 39). When transfected into
the cells, polyIC can induce robust IFN␣/␤ expression and
4

R. Wang, F. Huang, and Y.-L. Guo, unpublished data.
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We then analyzed the effects of silencing PKR and RIG-I on
polyIC-induced transcription of IFN␤ and IL6. siRNA targeting
PKR and RIG-I specifically knocked down their targets as
expected (Fig. 7C). Silencing PKR significantly reduced mRNA
levels of both IL6 and IFN␤, whereas silencing RIG-I slightly
attenuated transcription of IL6 but not that of IFN␤ (Fig. 7D).
PKR Is Activated by LACV but Not by WNV or SeV Infection
in mESCs—We analyzed whether or not PKR was activated in
virus-infected cells. As shown in Fig. 8A, a time course study of
LACV-infected cells indicated PKR was activated at 11 h postinfection and lasted up to 30 h as indicated by eIF2␣ phosphorylation, although the protein level of PKR was not altered as
determined by Western blot with PKR antibodies (Santa Cruz
Biotechnology). Knocking down PKR expression did not have
an apparent effect on LACV-induced cell death (Fig. 8B). Similar results were obtained in the experiments with the C16 PKR
inhibitor (data not shown). PKR activation by LACV was further confirmed by flow cytometry with antibodies against
p-eIF2␣; however, p-eIF2␣ was not detected in the cells
infected with WNV or SeV in parallel experiments (Fig. 8C).
These results suggested that PKR activation is virus-dependent
in mESCs.

mESCs Are Deficient in Type I IFN Expression

FIGURE 6. Relative mRNA levels of dsRNA receptors in mESCs and 10T1/2 cells. The mRNA levels of dsRNA receptors in D3 (A), DBA252 (B), and 10T1/2 (C)
were determined by RT-qPCR. Their relative abundance in each cell was determined by comparing with the mRNA level of ␤-actin (designated as 1). For a direct
comparison, the relative mRNA level of each molecule in D3 cells and 10T1/2 cells is presented in C. The results are means ⫾ S.D. of three independent
experiments in all panels.
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mESCs. Nevertheless, substantial evidence indicates that PKR
plays a key role in mediating the effects of polyIC, as demonstrated by the phosphorylation of eIF2␣ and the results
observed in the PKR silencing experiments. It is known that
IFN-induced activation of ribonuclease L (RNase L) can hydrolyze both cellular and viral RNA (14). Although polyIC could
lead to RNase L activation in some cells (45), this does not seem
to be the case in mESCs because polyIC did not cause rRNA
degradation (data not shown), which is a commonly used indicator of RNase L activation (45). The result further supports our
conclusion that polyIC could not induce a sufficient level of
IFN␣/␤ in mESCs for RNase L activation.
LACV infection also activated PKR in mESCs, similar to the
finding in murine embryonic fibroblasts (46). However, silencing or inhibition of PKR did not significantly affect LACV-induced cell death of mESCs, which is in line with the observation
that PKR activation has little impact on viral replication as demonstrated in PKR⫺/⫺ murine embryonic fibroblasts (46). PKR
activation has been implicated in apoptosis, but its roles are
stimulus- and virus-dependent (47). The effects of PKR activation by LACV on mESCs could be more complex than polyIC
due to the fact that many other cellular and viral factors are
involved during infection. Unlike LACV infection, we did not
detect PKR activation in the mESCs infected with WNV or SeV.
Failure to activate PKR by these viruses has been noted in other
cells. As recently reported in rodent cells, WNV infection does
not induce PKR activation, possibly by a mechanism that
sequesters viral dsRNA from host PKR (48). In the case of SeV,
it is proposed that PKR activation is repressed by the C protein
encoded by the virus (49). Whether or not these mechanisms
are utilized in mESCs remains to be investigated.
It is interesting to note that hESCs do not express IFN␣/␤
even at the mRNA level when transfected with polyIC (6, 16).
mESCs can express limited transcripts of Ifn␣/␤, Il6, and
Icam1, but they could not produce detectable levels of their
respective proteins. Thus, the transcription of these immune
mediators in mESCs may have limited function, if any, as an
antiviral mechanism. In speculating the physiological significance of dsRNA-induced cellular events in ESCs, it is worth
mentioning that in differentiated cells, dsRNA can be formed
under some circumstances, but they are retained in the nucleus
for editing and rarely exported to the cytoplasm (50). However,
the nuclear retention mechanism in ESCs is less effective. As a
result, dsRNAs may be exported to the cytoplasm in ESCs
where they activate dsRNA receptors (51). In addition, other
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other responses that are similar to those evoked by viral infection via cytoplasmic dsRNA receptors (32, 40). mESCs were
unresponsive to polyIC that was directly added to the medium,
likely due to the very low level expression of TLR3. However,
polyIC transfected into the mESCs showed a profound inhibitory effect on proliferation, a known effect of polyIC on many
types of differentiated cells, indicating that the cytoplasmic
receptors for polyIC are active in mESCs.
One of the distinctive features of mESCs is their rapid cell
proliferation that is driven by constitutively active Cdk2-cyclin
A/E complexes (41, 42). It is conceivable that actively dividing
mESCs are more sensitive to polyIC-inhibited translation
because cell proliferation critically depends on de novo protein
synthesis. We had expected that polyIC-inhibited cell proliferation could significantly affect their stem cell state. However,
morphology of the individual cells and colonies appeared to be
maintained at the undifferentiated state despite their transient
decrease in transcription of pluripotency markers. Because
polyIC caused similar changes to the transcription of differentiation markers, the effect is not gene-specific, but rather a general transcription disturbance similar to that caused by viral
infection (13). We speculate that the nonspecific transcription
interference might help mESCs maintain their stem cell state by
preventing the expression of genes that promote differentiation, at least for a short period of time under our experimental
conditions. PolyIC-induced cell cycle inhibition is transient
because polyIC-treated cells can resume a normal rate of proliferation in subculture when they were passed to new culture
dishes. Thus, the transient change of pluripotency and differentiation markers is not surprising because the experiments
were performed in the presence of leukemia inhibitory factor,
which maintains the pluripotency and prevents differentiation
of mESCs. This observation is in line with our recent study
demonstrating that transient inhibition of cell proliferation
does not compromise the stem cell state of mESCs (26).
It is generally believed that MDA5 and RIG-I play primary
roles in mediating viral RNA-induced IFN␣/␤ expression in the
cytoplasm (11, 39), although PKR also contributes to and modulates this process (13, 14). Because MDA5 is expressed at a
negligible level in mESCs, it is conceivable that PKR and/or
RIG-I may mediate the effects of transfected polyIC. However,
the RIG-I signaling pathway seems to be inactive because
silencing RIG-I did not affect the effects of polyIC and because
3p-ssRNA (5⬘-triphosphate single-stranded RNA), the best
studied ligands of RIG-I (43, 44), failed to induce IFN␤ in
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FIGURE 7. PKR plays key roles in mediating the effects of polyIC. A, polyIC-induced phosphorylation of eIF2␣. D3 cells were transfected with 300 ng/ml
polyIC and incubated for the times indicated. The cells with phosphorylated eIF2␣ (p-eIF2␣) were quantified by flow cytometry (boxed areas). White slash lines
were used to help identify the bottom sides of the boxes). The blot insets illustrate the levels of p-eIF2␣ and PKR determined by Western blot. Actin was used
as a loading control. B, effects of PKR and RIG-I silencing on polyIC-induced cellular events. D3 cells were transfected with siRNA against PKR (siPKR), RIG-I
(siRIG-I), or negative control siRNA (siNeg) for 24 h. The cells were split into new dishes. After 24 h, the cells were transfected with polyIC for 24 h and analyzed
for p-eIF2␣ by flow cytometry (upper panels), cell cycle by flow cytometry (middle panels, the changes in S and G2/M phase cells are indicated by the arrow and
arrowhead, respectively), and cell proliferation/colony formation by microscopy (lower panels). C and D, relative contributions of PKR and RIG-I to polyICinduced mRNA of IL6 and IFN␤. D3 cells were transfected with siPKR, siRIG-I, or negative control siRNA followed by polyIC treatment as described in B. The
mRNA levels of PKR and RIG-I (C) or IL6 and IFN␤ (D) were determined by RT-qPCR and compared with the mRNA in the cells that were transfected with negative
control siRNA (defined as 1) in each group. The results are means ⫾ S.D. of three independent experiments. The difference is considered to be statistically
significant when p ⬍ 0.05 (*). All representative experiments in A and B were performed at least twice with similar results.

types of abnormal RNAs, such as those derived from cell death
or from RNA processing, could activate PKR (52, 53). In particular, PKR is considered to be a “sentinel kinase for stress” for its
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involvement in stress response in addition to antiviral response
(54). Therefore, it appears that dsRNA-induced inhibition of
translation and cell proliferation in mESCs could be an imporVOLUME 288 • NUMBER 22 • MAY 31, 2013
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tant mechanism that helps cells deal with immunogenic
stresses.
In summary, our study demonstrates that expression of type
I IFN as a crucial part of antiviral responses is underdeveloped
in mESCs. Our study may open up an important area in ESC
research for understanding the development of antiviral mechanisms during embryogenesis and how the stress caused by
immunogenic signals affects ESC physiology.
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